Edition:
United Kingdom

Aradigm Corp (ARDM.OQ)

ARDM.OQ on NASDAQ Stock Exchange Capital Market

1.23USD
20 Sep 2018
Change (% chg)

$0.04 (+3.36%)
Prev Close
$1.19
Open
$1.19
Day's High
$1.23
Day's Low
$1.19
Volume
5,371
Avg. Vol
6,401
52-wk High
$7.26
52-wk Low
$1.04

Chart for

About

Aradigm Corporation is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company's lead product candidate is Pulmaquin inhaled ciprofloxacin, which is in Phase III clinical trials. It offers AERx pulmonary drug delivery... (more)

Overall

Beta: 8.71
Market Cap(Mil.): $18.09
Shares Outstanding(Mil.): 15.20
Dividend: --
Yield (%): --

Financials

  ARDM.OQ Industry Sector
P/E (TTM): -- 107.68 32.65
EPS (TTM): -1.11 -- --
ROI: -375.23 1.61 12.72
ROE: -- 0.32 14.84

BRIEF-Aradigm Announces EMA Has Completed Its Validation Of The MAA Submission

* ARADIGM ANNOUNCES THE EMA HAS COMPLETED ITS VALIDATION OF THE MAA SUBMISSION

05 Apr 2018

BRIEF-Aradigm Reports Q4 Loss Per Share Of $0.28

* ARADIGM ANNOUNCES FOURTH QUARTER 2017 AND FULL YEAR FINANCIAL RESULTS

23 Mar 2018

Earnings vs. Estimates